(Update) Acalabrutinib in CLL and MCL
Update Venetoclax in CLL
Acalabrutinib
Obinutuzumab
Zanubrutinib
Cancer.gov
NCCN Guidelines for Patients
NCCN COVID-19 Resources Page
UpToDate